From REDEFINE-1: Nausea: 55% of CagriSema participants vs 12.6% with placebo Constipation: 30.7% vs 11.6% Vomiting: 26.1% vs 4.1% Discontinuation rate: 5.9% vs 3.5% placebo comparable to Wegovy (6.9%) and Zepbound (6.2%) The nausea rate (55%) is higher than the ~4045% typical for semaglutide alone
This was due to the stronger mucoadhesiveness of AMS-NE-ISG, along with potential interactions between the polymers used for AMS-NE-ISG and the nasal membrane
1b): 7,8,9,10,11,12,15,17,19,30 During the oxidative half-reaction the thiolate group of the reduced glutaredoxin attacks the GSSR disulfide bond, yielding the first product (RSH) and the glutathionylated glutaredoxin Grx(SSG) as an intermediate
International Journal of Gynecological Cancer, 6: 415419
The combination guide and stack calculator help plan multi-peptide protocols
Reconstitute with sterile bacteriostatic water under sterile conditions